Skip to content

Clinical trials

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Country / region: Russia Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20064
20072
20081
20091
20103
20111
20121
20133
20153
20161
20171
20182
20201
20213
20222
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting7
Terminated4
Unknown status3
No longer available1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals13
Bristol-Myers Squibb5
St. Petersburg State Pavlov Medical University5
Pfizer3
Ascentage Pharma Group Inc.1
European Society for Blood and Marrow Transplantation1
Fusion Pharma LLC1
Hoffmann-La Roche1
Il-Yang Pharm. Co., Ltd.1
Kartos Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive35
Leukemia6
Leukemia, Myeloid, Chronic-Phase6
Myelodysplastic Syndromes6
Myeloproliferative Disorders6
Leukemia, Myeloid, Acute4
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Bone Marrow Diseases3
Bronchiolitis Obliterans Syndrome3
Hematologic Diseases3

Trials

Showing 26 to 35 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.